Relationship between time to trastuzumab initiation and overall survival among young commercially insured women with metastatic breast cancer

被引：0
|
作者：
Leopold, Christine
Zhang, Fang
Wagner, Anita K.
Lu, Christine Y.
Earle, Craig
Ross-Degnan, Dennis
Wharam, James Frank
机构：
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Harvard Pilgrim Inst, Dept Populat Med, Drug Policy Res Grp, Boston, MA USA
[3] Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA
[4] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[5] Ontario Inst Canc Res, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e18013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18013
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Racial/Ethnic Segregation and Inequities in Metastatic Breast Cancer Treatment Initiation and Overall Survival
    Guadamuz, Jenny S.
    Calip, Gregory S.
    Asfaw, Alemseged A.
    Wang, Xiaoliang
    Pittell, Harlan
    Kaur, Maneet
    Pierre, Amy E.
    Ryals, Cleo A.
    CANCER RESEARCH, 2023, 83 (05)
  • [22] RELATIONSHIP BETWEEN LYMPHOPENIA AND CIRCULATING TUMOR CELLS AS PROGNOSTIC FACTORS FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    De Giorgi, U.
    Mego, M.
    Scarpi, E.
    Handy, B. C.
    Jackson, S. A.
    Reuben, J.
    Valero, V.
    Hortobagyi, G. N.
    Ueno, N.
    Cristofanilli, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 67 - 67
  • [23] Relationship Between Lymphocytopenia and Circulating Tumor Cells as Prognostic Factors for Overall Survival in Metastatic Breast Cancer
    De Giorgi, Ugo
    Mego, Michal
    Scarpi, Emanuela
    Giuliano, Mario
    Giordano, Antonio
    Reuben, James M.
    Valero, Vicente
    Ueno, Naoto T.
    Hortobagyi, Gabriel N.
    Cristofanilli, Massimo
    CLINICAL BREAST CANCER, 2012, 12 (04) : 264 - 269
  • [24] Meta Analysis to Compare Overall Survival Between Primary Metastatic Breast Cancer and Recurrent Metastatic Breast Cancer
    Aseyev, O.
    Alanbagi, A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S113 - S113
  • [25] Overall Survival Advantage through Ribociclib for premenopausal Women with metastatic Breast Cancer
    Ruckhaeberle, E.
    ONKOLOGE, 2020, 26 (07): : 656 - 657
  • [26] Intensity of End-of-Life Care in a Cohort of Commercially Insured Women With Metastatic Breast Cancer in the United States
    Ferrario, Alessandra
    Xu, Xin
    Zhang, Fang
    Ross-Degnan, Dennis
    Wharam, J. Frank
    Wagner, Anita K.
    JCO ONCOLOGY PRACTICE, 2021, 17 (02) : E194 - E203
  • [27] Survival in Young Women with De Novo or Recurrent Metastatic Breast Cancer
    Varella, Leticia
    Zheng, Yue
    Rosenberg, Shoshana
    Kirkner, Gregory
    Snow, Craig
    Ruddy, Kathryn
    Tamimi, Rulla
    Peppercorn, Jeffrey
    Schapira, Lidia
    Borges, Virginia
    Come, Steven
    Collins, Laura
    Warner, Ellen
    Dibble, Kate
    Winer, Eric
    Partridge, Ann
    CANCER RESEARCH, 2024, 84 (09)
  • [28] Overall survival and time to disease progression improved in metastatic breast cancer patients
    不详
    ONCOLOGY-NEW YORK, 2004, 18 (03): : 338 - 338
  • [29] Young women with breast cancer: Does surgical approach impact overall survival?
    Pestana, Christine
    Trufan, Sally
    Schepel, Courtney
    Sarantou, Terry
    White, Richard
    Hadzikadic-Gusic, Lejla
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 46 - 47
  • [30] Multidimensional financial hardship among uninsured and insured young adult patients with metastatic breast cancer
    Wheeler, Stephanie B.
    Spencer, Jennifer C.
    Manning, Michelle L.
    Samuel, Cleo A.
    Reeder-Hayes, Katherine E.
    Greenup, Rachel A.
    Spees, Lisa P.
    Rosenstein, Donald L.
    CANCER MEDICINE, 2023, 12 (10): : 11930 - 11940
12345